Ventus Therapeutics announced the successful completion of the phase 1 clinical trial for VENT-03 with plans to initiate a ...

ADC Therapeutics has stopped development of lead solid tumor candidate ADCT-601. The biotech axed the AXL-directed ...

--(BUSINESS WIRE)--Septerna, a clinical-stage biotechnology company pioneering a new era of GPCR-targeted drug discovery, today announced the dosing of the first participants in its Phase 1 ...

Ventus Therapeutics, a clinical-stage biopharmaceutical company utilizing its proprietary ReSOLVE™ platform to discover and ...

TD Cowen analyst Ritu Baral has maintained their bullish stance on TERN stock, giving a Buy rating yesterday. Ritu Baral has given his Buy ...

See what moon phase it is tonight and find out when you can see the rest of the moon phases for 2024. Today, Nov. 14, 2024, the moon is 13 days old and is in the Waxing Gibbous phase of its lunar ...

The phase 1, open label clinical study is designed to enroll up to 10 participants and is being conducted in Johannesburg, Pretoria, and Bloemfontein, South Africa. This is the first cellular ...

Daina Graybosch’s rating is based on the promising results from Century Therapeutics’ Phase 1 trial of CNTY-101 in treating B-cell malignancies. The trial outcomes indicate a positive and clear dose ...

The $73 million design phase contract awarded to Omaha, Nebraska-based Kiewit Corp. is a down payment on what is expected to ...

The push-up is a well-known bodyweight exercise that builds upper body strength, targets the pecs, anterior deltoids ...